These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 31263147
1. Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved. Liu Q, Wu J, Lu T, Fang Z, Huang Z, Lu S, Dai C, Li M. Cell Death Dis; 2019 Jul 01; 10(7):509. PubMed ID: 31263147 [Abstract] [Full Text] [Related]
3. Clinicopathological significance of BTF3 expression in colorectal cancer. Wang CJ, Frånbergh-Karlson H, Wang DW, Arbman G, Zhang H, Sun XF. Tumour Biol; 2013 Aug 01; 34(4):2141-6. PubMed ID: 23532689 [Abstract] [Full Text] [Related]
4. Basic transcription factor 3 is involved in gastric cancer development and progression. Liu Q, Zhou JP, Li B, Huang ZC, Dong HY, Li GY, Zhou K, Nie SL. World J Gastroenterol; 2013 Jul 28; 19(28):4495-503. PubMed ID: 23901224 [Abstract] [Full Text] [Related]
5. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1. Zhang J, Wang Y, Shen Y, He P, Ding J, Chen Y. Theranostics; 2018 Jul 28; 8(10):2884-2895. PubMed ID: 29774081 [Abstract] [Full Text] [Related]
7. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R, Shi H, Ren F, Liu H, Zhang M, Deng Y, Li X. Oncol Rep; 2015 Mar 28; 33(3):1235-42. PubMed ID: 25592872 [Abstract] [Full Text] [Related]
8. MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level. Li SS, Zhu HJ, Li JY, Tian LM, Lv DM. Eur Rev Med Pharmacol Sci; 2020 Feb 28; 24(3):1126-1133. PubMed ID: 32096168 [Abstract] [Full Text] [Related]
10. Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma. Zhang Y, Gross N, Li Z, Yin G, Zhong Q, Liu C, Huang Z. Biomed Pharmacother; 2019 Oct 28; 118():109211. PubMed ID: 31404775 [Abstract] [Full Text] [Related]
13. PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3. Gao Z, Man X, Li Z, Bi J, Liu X, Li Z, Li J, Zhang Z, Kong C. Cancer Gene Ther; 2020 Jun 28; 27(6):412-423. PubMed ID: 31186514 [Abstract] [Full Text] [Related]
14. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. Wang L, Shi S, Guo Z, Zhang X, Han S, Yang A, Wen W, Zhu Q. PLoS One; 2013 Jun 28; 8(6):e65539. PubMed ID: 23762387 [Abstract] [Full Text] [Related]
15. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway. Xu C, Sun L, Jiang C, Zhou H, Gu L, Liu Y, Xu Q. Biomed Pharmacother; 2017 Jul 28; 91():1167-1177. PubMed ID: 28531945 [Abstract] [Full Text] [Related]
16. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition. Herz C, Schlürmann F, Batarello D, Fichter CD, Schöpflin A, Münch C, Hauschke D, Werner M, Lassmann S. Mol Carcinog; 2012 Sep 28; 51(9):696-710. PubMed ID: 21739483 [Abstract] [Full Text] [Related]
17. Polo-like kinase 1 expression is suppressed by CCAAT/enhancer-binding protein α to mediate colon carcinoma cell differentiation and apoptosis. Dasgupta N, Thakur BK, Ta A, Das S, Banik G, Das S. Biochim Biophys Acta Gen Subj; 2017 Jul 28; 1861(7):1777-1787. PubMed ID: 28341486 [Abstract] [Full Text] [Related]
18. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer. Wang J, Yu S, Cui L, Wang W, Li J, Wang K, Lao X. BMC Cancer; 2015 Mar 04; 15():90. PubMed ID: 25884313 [Abstract] [Full Text] [Related]
19. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway. Yu M, Cui R, Huang Y, Luo Y, Qin S, Zhong M. EBioMedicine; 2019 Oct 04; 48():264-276. PubMed ID: 31530502 [Abstract] [Full Text] [Related]
20. MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation. Li Y, Li L, Chen M, Yu X, Gu Z, Qiu H, Qin G, Long Q, Fu X, Liu T, Li W, Huang W, Shi D, Kang T, Luo M, Wu X, Deng W. Mol Oncol; 2018 Mar 04; 12(3):391-405. PubMed ID: 29360267 [Abstract] [Full Text] [Related] Page: [Next] [New Search]